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Zika virus (ZIKV) is a flavivirus closely related to dengue virus (DENV), West Nile virus, and yellow fever virus. Transmission is primarily via mosquito vectors, although sexual transmission has recently been documented [1] . The first major outbreak of ZIKV infection occurred in Yap (Federated States of Micronesia) in 2007 [2] , and outbreaks in Southeast Asia and the Western Pacific followed [3] .
Singapore, an island city-state in Southeast Asia reported its first case of locally transmitted ZIKV infection on 27 August 2016 [4] . The Singapore Ministry of Health initiated a containment phase of active screening of confirmed and suspected cases. Our hospital, KK Women's and Children's Hospital, was the designated ZIKV quarantine hospital for all confirmed and suspected pediatric cases during the containment phase. On 5 September 2016, the Ministry of Health ceased mandatory admission for patients with confirmed ZIKV infection [5] . We report a series of 14 pediatric patients with ZIKV infection admitted and isolated during this period.
MATERIALS AND METHODS

Study Setting and ZIKV Case Definitions
During the containment phase from 27 August to 5 September 2016, infants, children, and adolescents aged ≤16 years with confirmed or suspected ZIKV infection had to be admitted and isolated in KK Women's and Children's Hospital, the largest pediatric hospital in Singapore. The following case definitions were used [6] . Suspected case patients included any individual (1) with possible exposure to ZIKV, including recent travel history (within 2 weeks) to ZIKV-affected countries or living or working near a confirmed ZIKV case (within 6 weeks of that case's isolation) or in an area with ongoing ZIKV transmission and (2) presenting symptoms of fever, maculopapular rash, and any of the following: arthralgia, myalgia, headache, and nonpurulent conjunctivitis. Confirmed case patients were those with laboratory confirmation of acute ZIKV infection.
All confirmed case patients during the containment phase were included in the case series.
Clinical and Laboratory Data
All suspected pediatric ZIKV case patients were screened for symptoms in the case definition and had both serum and urine samples tested for ZIKV polymerase chain reaction (PCR). They were also routinely screened for cough or rhinorrhea. Results of all laboratory investigations performed during their admission were retrieved from hospital laboratory databases.
We used a ZIKV reverse-transcription PCR optimized to run on the Rotorgene RG3000, 6000, or Q instrument (Corbett Research Qiagen). It was adapted from a protocol published by Lanciotti et al [7] . Patients were also tested for dengue and Chikungunya infections. In those who reported cough or rhinorrhea, a nasopharyngeal swab sample was obtained, and immunofluorescence testing was performed for a panel of common respiratory viruses. Table 1 shows the demographic data for 14 children and adolescents with acute ZIKV infection who presented at our institution. The mean patient age was 11 years (range, 6 months to 16 years), and the sex distribution was equal. The majority of patients (12 of 14) were of Chinese ethnicity, and the remaining 2 were Indian and Malay. Table 1 summarizes the clinical and laboratory data for the 14 patients in the pediatric ZIKV case series. None of the patients had a history of travel outside of Singapore within 14 days before presentation, and none had any comorbid conditions.
RESULTS
Demographic Characteristics
Clinical Presentation and Course
The most commonly reported initial symptom experienced was fever (n = 9; 64%), followed by rash (n = 7; 50%). All 14 Table 1 patients reported a maculopapular rash during the course of illness, with a median duration of 2 days before presentation. The maximum duration of rash for the entire course of illness among patients with ZIKV infection only (n = 13) was 4 days. Only 2 patients (14%) reported arthralgia, 1 of whom had dengue coinfection. Four patients (29%) reported nonpurulent conjunctivitis, and 3 (21%) reported headache and myalgia at presentation. The highest temperature recorded in the 13 patients with ZIKV infection alone was 38.5°C, with a mean duration of 2.3 days (range, 0-5 days). Of our pediatric cohort, 50% also reported concurrent cough or coryza at presentation. All patients were treated symptomatically and were well at discharge. None required a higher level of care in high-dependency or intensive care units.
Laboratory Investigations
All 14 patients tested positive for ZIKV PCR in urine samples. Serum samples from only 2 children (patients 2 and 9) were positive for ZIKV PCR. Repeated ZIKV PCR testing of serum samples from these 2 patients within 24 hours had negative results. One patient (patient 13) had acute coinfection with DENV, and no patients had positive serological results for Chikungunya virus. In 12 of 14 patients (86%), a complete blood cell count was performed on the day of presentation. Four of 12 (33%) had leukopenia for their corresponding age-specific ranges, 2 (17%) had neutropenia, and 4 (33%) had lymphopenia. None of the patients had leukocytosis. All who had a complete blood cell count performed had normal platelet counts. C-reactive protein was measured in 3 patients, all with normal results. For all nasopharyngeal swab samples from obtained patients with reported upper respiratory tract symptoms, results of immunofluorescence for common respiratory viruses were negative.
Patient With Acute ZIKV and DENV Coinfection
Patient 13 was a 15-year-old Chinese boy who presented with fever, rash, bilateral knee pain, and headache. Serum samples obtained on the first day of symptom onset were positive for DENV PCR and NS1 antigen and negative for DENV immunoglobulin G and M, and a urine sample was positive for ZIKV PCR. The patient developed mild nonsuppurative bilateral conjunctivitis that lasted for 2 days during his hospital stay. On day 3 of his illness, an episode of hypotension occurred (systolic blood pressure, 95 mm Hg), which resolved with intravenous hydration. A complete blood cell count on the first day of illness showed lymphopenia and normal platelet count. Thrombocytopenia subsequently developed on day 3 of the patient's illness, and his platelet count reached a nadir of 74 × 10 9 /L before showing a rising trend before discharge. He did not require any blood product transfusion. A liver function test did not reveal any transaminitis (alanine transaminase, 19 U/L; aspartate transaminase, 34 U/L). The patient's febrile illness lasted for 5 days, with a maximum temperature of 40.5°C recorded on the second day of illness. He was well at hospital discharge.
DISCUSSION
To our knowledge, this is the first pediatric case series of virologically confirmed ZIKV infections from Southeast Asia. In our analysis, pediatric ZIKV infection was generally a mild disease. Although the small number of patients limits the generalizability of these results, no deaths or neurological complications after ZIKV infection were reported in our case series and another large pediatric case series in North America [8] . The clinical course of the patient who had evidence of both ZIKV and DENV infections was slightly more severe. It is difficult to be certain whether he acquired ZIKV or DENV first. Based on the available laboratory results at presentation, one could postulate that the DENV infection developed closely before or after the ZIKV infection. Whether the clinical course of the patient's DENV infection was exacerbated by his earlier or concurrent ZIKV infection is difficult to conclude. There is still ongoing debate as to whether antibody dependent enhancement could occur between ZIKV and DENV infection, because they are both from the same Flaviviridae family [9] . Routine screening of pediatric patients with suspected ZIKV infection for DENV coinfection should be considered in dengue-endemic countries, because current evidence seems to suggest that these patients may require more clinical support.
The ZIKV detected in the initial cases in Singapore has been shown to arise from the Asian strain [10] . All pediatric patients in this case series were within the same epidemiological cluster as the initial case patients whose ZIKVs were sequenced, and none had a history of recent travel before presentation. Our case series provides early evidence that the clinical course of the Southeast Asia ZIKV strain is also mild in most children, as in pediatric case reports from the Americas [8] .
All 14 patients in this series had negative ZIKV reverse-transcription PCR results in urine samples at presentation. Only 2 had positive serum ZIKV PCR, and later results were negative when the test was repeated within 24 hours. This suggests that urine ZIKV PCR alone, a noninvasive test, may be appropriate for confirming acute ZIKV infection in suspected pediatric cases [11] .
Neurological complications and deaths arising from pediatric ZIKV infection have rarely been reported [12] . Long-term prospective studies are required to evaluate the incidence of severe disease and possible complications associated with ZIKV infections in the pediatric population.
In conclusion, we found that acute pediatric ZIKV infections in Southeast Asia were similarly mild as those in to case reports of pediatric ZIKV infection from the Americas. There was some evidence that DENV and ZIKV coinfection resulted in more severe illness. With ZIKV infection increasingly reported and its complications not fully understood, clinicians should be cognizant of ZIKV as a cause of nonspecific symptoms in children and adolescents, as well as potential neurological sequelae.
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